Cengild Medical Bhd (XKLS:0243) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0243 Cengild Medical Bhd XKLS:0243
57 GF Score
Price RM0.20
GF Value RM0.26
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

XKLS:0243
57GF Score
Cengild Medical Bhd XKLS:0243
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.20 is trading 25% below its estimated GF Value™ of RM0.26. GuruFocus considers Cengild Medical Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0243:

  • Receipts from Customers:
  • GF Value™: RM0.26 vs. price of RM0.20 (25% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
57GF Score

Get the complete analysis for XKLS:0243

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.20
Price
RM0.26
GF Value